OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Recommended Journals
Relevant Topics
- Ablation Surgery
- Acute Coronary Syndrome
- Advanced Medications for Atherosclerosis
- Angina Pectoris
- Angiogenesis
- Angiography
- Aortic Dissection
- Aortic Valve Replacement
- Arrhythmia
- Arrhythmia management
- Arrhythmia medications
- Atherosclerosis
- Atherosclerosis Diagnosis
- Atherosclerosis Pathology
- Atherosclerosis Research
- Atherosclerosis Statistics
- Atherosclerosis Surgery
- Atrial Fibrillation
- Atrial arrhythmia
- Benign arrhythmia
- Bypass Surgery
- Cardiac Catheterization
- Cardiac Electrophysiology
- Cardiac Surgery
- Cardiac arrhythmia
- Cardiac biomarkers
- Cardiomyopathy
- Cardiopulmonary Arrhythmia
- Cardiovascular Diseases
- Carotid Stenosis
- Congenital Heart Disease
- Coronary Artery Disease
- Echocardiography
- Endocarditis
- Endothelial Dysfunction Atherosclerosis
- Etiology of Atherosclerosis
- Fetal arrhythmia
- Heart Ablation
- Heart Attack
- Heart Diseases
- Heart Failure
- Heart Murmurs
- Heart Stent
- Heart Transplants
- Heart arrhythmia treatment
- Homocysteine in Atherosclerosis
- Intracranial Atherosclerosis
- Invasive Cardiology
- Obesity and Atherosclerosis
- Occlusive Coronary Atherosclerosis
- Open Heart Surgery
- Percutaneous Coronary Intervention
- Pulmonary Embolism
- Renal Atherosclerosis
- Sudden Cardiac arrest
- Vascular Atherosclerosis
- Vascular Surgery
Wolff-Parkinson-White Syndrome
-
Pathophysiology
Wolff-Parkinson-White (WPW) syndrome is a condition in which episodes of fast heart rate (called tachycardia) occur because of an abnormal extra electrical pathway in the heart. People with WPW may experience palpitations, dizziness, lightheadedness, and fainting, although some people with WPW have no symptoms.
-
Statistics
The prevalence rate for chronic Wolff-Parkinson-White syndrome has been estimated as 10% per 60,000.
-
Treatment
Medicines, particularly antiarrhythmic drugs such as procainamide or amiodarone, may be used to control or prevent a rapid heartbeat.
-
Major research
Researchers at the British Heart Foundation are working on several treatment options for Wolff-Parkinson-White syndrome.
Expert PPTs
- PRAVIN D. POTDAR
Importance of Molecular Diagnostics in state of Maharashtra
PPT Version | PDF Version - Tahir Saeed
Autism Spectrum Disorder
PPT Version | PDF Version - Weiqin Chen
Obesity
PPT Version | PDF Version - Hong Wang
Presentation-Insulin
PPT Version | PDF Version - Liang-Kung Chen
Frailty & Sarcopenia
PPT Version | PDF Version - Yuanlin Song
ARDS, lung infectious disease
PPT Version - Lavjay Butani
Kidney Transplantation
PPT Version | PDF Version - Denis Hadjiliadis
Susceptibility of CF patients to Pseudomonas acquisition
PPT Version - Suresh Kumar K Thallapuranam
Structure, Folding, and Interactions of the Fibroblast Growth Factors
PPT Version | PDF Version
Speaker PPTs
- Georgia Torres
Effect of exercise intervention programs on anthropometric, physiological and cardiometabolic parameters of persons with and without metabolic syndrome
PPT Version | PDF Version - Mandob Enyegue Damaris
Prevalence of metabolic syndrome among University of Yaounde I campus police workers
PPT Version | PDF Version - Danielle Venturini
Increased oxidative stress according to number of risk factors in metabolic syndrome patients
PPT Version | PDF Version - Laidoudi Aicha
Acute renal failure and uveitis, which diagnosis is most likely in internal medicine? Tinu syndrome, through two observations
PPT Version | PDF Version - Emanuele Corongiu
Role of percutaneous tibial nerve stimulation in the treatment of neurogenic overactive bladder syndrome.
PPT Version | PDF Version - Randhawa Ramanpreet
Receiver Operating Characteristic curve analysis of Anthropometric Physiological and Biochemical indices and a comparison between four International definitions JSS, mATP-III, IDF and ATP-III for screening Metabolic Syndrome among Pre- and Postmenopausal Rural females of Amritsar (Punjab)
PPT Version | PDF Version - Nisreen K Aref
To compare serum leptin levels in obese women with polycystic ovary syndrome (PCOS) and normal ovulatory obese subjects in Saudi Arabia, and to evaluate the interrelationship between leptin concentration, sex hormones, and insulin resistance.
PPT Version | PDF Version - Elena Rampanelli
Renal dysfunction and metabolic syndrome: the chicken or the egg?
PPT Version | PDF Version - David Stejskal
New marker of metabolic syndrome
PPT Version | PDF Version - Vladimir Obolensky
No-air-plasma currents and ozone therapy in treatment of patients with diabetic foot syndrome
PPT Version | PDF Version - Kirill Shlyapnikov
Fibromyalgia and chronic fatigue syndrome (CFS): translational biomarkers as applicable to monitor and to predict clinical manifestations
PPT Version | PDF Version - Ljudmila Stojanovich
The risk of thrombosis in patients with antiphospholipid syndrome: Influence of antiphospholipid antibody type and levels
PPT Version | PDF Version - Tamer I Mahmoud
Early Life Intervention Diminishes Manifestations of Sjögren's Syndrome in NOD.H-2h4 mice
PPT Version | PDF Version - Calsolaro Valeria
METABOLIC SYNDROME, NEUROINFLAMMATION AND COGNITIVE IMPAIRMENT: STATE OF THE ART AND DATA FROM A SECOND LEVEL OUTPATIENT CLINIC IN ITALY
PPT Version | PDF Version - Mariana Artimos da Matta Tenorio
Wilkieâs Syndrome: A Case Report
PPT Version | PDF Version - Alex Constantinescu
Strategies to minimize growth retardation in children with Steroid-sensitive nephrotic syndrome
PPT Version | PDF Version - Irma Esther Del Moral Espinosa
Effectiveness of combination prednisone tacrolimus compared with prednisone -cyclosporine in treatment steroid-resistant nephrotic syndrome
PPT Version | PDF Version - Pupalan Iyngkaran
Region Specific Cardiology Perspectives on the Cardiorenal Syndrome â Challenges and Solutions
PPT Version | PDF Version - Sandra Rasmussen
Live well: A recovery model for addiction and other reward deficiency syndrome
PPT Version | PDF Version - Emmanuel C. Besa
New opportunities in a personalized approach to the preleukemic phase of myelodysplastic syndrome and acute myelogenous leukemia
PPT Version | PDF Version - Amera Elzubier
Lemierres syndrome: The forgotten disease? A case report
PPT Version | PDF Version - Malgorzata Lipinska Gediga
Endothelium as a part of septic Multiple Organ Dysfunction Syndrome (MODS)-is endocan an answer ?
PPT Version | PDF Version - Martha M Sklavos
PDF Version - Tao Wu
The association between TCM syndromes and SCAP polymorphisms insubjects with non-alcoholic fatty liver disease
PPT Version | PDF Version - Galya Naydenova Atanasova
Pulse pressure and apolipoprotein B/Apolipoprotein A1 in relation to the metabolic syndrome and its components
PPT Version | PDF Version - Edward Rojas
PDF Version